Literature DB >> 12784095

Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.

Haruo Mizuno1, Shinji Fujimoto, Yukari Sugiyama, Masanori Kobayashi, Yoichiro Ohro, Shinichi Uchida, Sei Sasaki, Hajime Togari.   

Abstract

OBJECTIVE: To clarify whether combination treatment with desmopressin (DDAVP) and thiazide was clinically effective in a patient with congenital nephrogenic diabetes insipidus (CNDI), we evaluated the treatment in a 7-year-old boy with CNDI who had demonstrated a partial response to DDAVP.
METHOD: Both volume of urine and the presence of nocturia were determined during treatment. RESULT: Neither the usual therapy of a low-salt diet and a thiazide nor intranasal therapy with a large dose of DDAVP was effective. However, combination treatment resulted in a decrease in urinary volume and the disappearance of nocturia.
CONCLUSION: DDAVP coupled with thiazide may be useful for CNDI in patients who have shown a partial response to DDAVP. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784095     DOI: 10.1159/000070629

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

1.  Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.

Authors:  Masanobu Fujimoto; Shin-Ichi Okada; Yuki Kawashima; Rei Nishimura; Naoki Miyahara; Yasuo Kawaba; Keiichi Hanaki; Eiji Nanba; Yoshiaki Kondo; Takashi Igarashi; Susumu Kanzaki
Journal:  Yonago Acta Med       Date:  2014-07-30       Impact factor: 1.641

2.  Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.

Authors:  Haruo Mizuno; Yukari Sugiyama; Yoichiro Ohro; Hiroki Imamine; Masanori Kobayashi; Sei Sasaki; Sinichi Uchida; Hajime Togari
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

3.  Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report.

Authors:  Kento Ikegawa; Rumi Hachiya; Kazuhisa Akiba; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2022-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.